Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen

Pancreatic cancer is the fourth largest cause of cancer deaths in the Unites States and the prognosis is grim with <5% survival chances upon diagnosis. The objective of this study was to assess the combined chemopreventive effect of solid lipid nanoparticle (SLN) encapsulated drugs aspirin (ASP),...

Descripción completa

Detalles Bibliográficos
Autores principales: SUTARIA, DHRUVITKUMAR, GRANDHI, BALAGANGADHAR KARTHIK, THAKKAR, ARVIND, WANG, JEFFREY, PRABHU, SUNIL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583628/
https://www.ncbi.nlm.nih.gov/pubmed/23007664
http://dx.doi.org/10.3892/ijo.2012.1636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583628/
https://www.ncbi.nlm.nih.gov/pubmed/23007664
http://dx.doi.org/10.3892/ijo.2012.1636

Ejemplares similares